Plain-English translation of NCT06321003 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether Optical Coherence Tomography (OCT)—a non-invasive imaging technology—can accurately diagnose potentially precancerous and cancerous lesions in the mouth. Instead of requiring a painful biopsy, this scanner takes detailed pictures of mouth tissue to look for early warning signs of oral cancer.
Current methods for diagnosing oral cancer often require invasive biopsies that are time-consuming and painful, which can delay treatment. This trial exists to see if this imaging technology could help doctors spot suspicious lesions earlier and more easily, without the need for invasive procedures.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the OCT imaging scan, which allows doctors to take detailed pictures of any suspicious areas in your mouth. The scan is painless and non-invasive—the device simply uses light to visualize the tissue layers. You may also have your medical records reviewed as part of the study. The trial is expected to involve 200 participants total, and researchers will use the images collected to teach computer algorithms to recognize cancerous and precancerous changes more accurately.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy